Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.

Mück-Seler D, Jakovljević M, Deanović Z.

J Affect Disord. 1991 Nov;23(3):157-64.

PMID:
1774431
2.

Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.

Hrdina PD, Bakish D, Ravindran A, Chudzik J, Cavazzoni P, Lapierre YD.

Psychiatry Res. 1997 Feb 7;66(2-3):73-85.

PMID:
9075272
4.

Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments.

Pérez V, Bel N, Celada P, Ortiz J, Alvarez E, Artigas F.

J Clin Psychopharmacol. 1998 Jun;18(3):222-30.

PMID:
9617981
5.

Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.

Bakish D, Cavazzoni P, Chudzik J, Ravindran A, Hrdina PD.

Biol Psychiatry. 1997 Jan 15;41(2):184-90.

PMID:
9018388
6.

Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.

Birkenhäger TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1084-8. Epub 2007 Mar 28.

PMID:
17467132
7.

A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.

Pigott TA, L'Heureux F, Rubenstein CS, Bernstein SE, Hill JL, Murphy DL.

J Clin Psychopharmacol. 1992 Jun;12(3):156-62.

PMID:
1629380
8.
9.

Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.

Schlake HP, Kuhs H, Rolf LH, Bosse T, Schuhknecht E, Rudolf GA, Brune GG.

Acta Psychiatr Scand Suppl. 1989;350:149-51. No abstract available.

PMID:
2530775
10.

The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression.

Mück-Seler D, Pivac N, Sagud M, Jakovljević M, Mihaljević-Peles A.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Dec;26(7-8):1235-43.

PMID:
12502009
11.
12.
14.

Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.

Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pecquery R, Launay JM, Perez-Diaz F, Spreux-Varoquaux O.

Clin Pharmacol Ther. 1999 Dec;66(6):617-24.

PMID:
10613618
16.

Clovoxamine in the treatment of depressed outpatients: a double-blind, parallel-group comparison against amitriptyline and placebo.

Gelenberg AJ, Wojcik JD, Falk WE, Spring B, Brotman AW, Galvin-Nadeau M.

Compr Psychiatry. 1990 Jul-Aug;31(4):307-14.

PMID:
2201481
18.

The antidepressant effects of trazodone and inhibition of platelet serotonin reuptake.

Mann JJ, Friedman E, Georgotas A, Gershon S.

Commun Psychopharmacol. 1980;4(4):293-301. No abstract available.

PMID:
7273703
19.

[Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].

Katasonov AB, Beliaev BS, Zlobina GP, Faktor MI, Brusov OS.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1989;89(2):125-8. Russian.

PMID:
2728713
20.

A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.

Gelenberg AJ, Wojcik JD, Newell C, Lamping DL, Spring B.

J Clin Psychopharmacol. 1985 Feb;5(1):30-4.

PMID:
3882774

Supplemental Content

Support Center